Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
脑安滴丸
- Development stage
- Unknown
- Lead developer
- Lei Yun Shang
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
脑安滴丸是一种中成药制剂，主要成分包括川芎、当归、红花、人参和冰片。该药物以活血化瘀、益气通络为主要功效，常用于脑血栓形成的急性期和恢复期，以及半身不遂、口舌歪斜、偏身麻木、口角流涎、脑供血不足和血管性头痛等症状的治疗与中风预防。其作用机制主要涉及改善微循环，促进血液流动，减少血瘀，并通过补气增强机体康复能力[1][3]。本品为黑褐色至黑色的滴丸，有清香气味及苦味[1][3]。
- Brand names
- 脑安滴丸
- Other names
- Nao'an滴丸Nao'an Diwan
Beyond the preview
Go deeper on 脑安滴丸.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 脑安滴丸.